Determination of in vitro postantibiotic effects in Staphylococcus aureus and Escherichia coli by [3H]thymidine incorporation

Clinical Microbiology and Infection

Volumn 2, Issue 2, 1996, Pages 99-104

  Gottfredsson, Magnús ^a   Erlendsdóttir, Helga ^a   Gudmundsson, Adalsteinn ^a   Gudmundsson, Sigurdur ^a,b,c  

^a Department of Internal Medicine   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

E. coli; Postantibiotic effect; S. aureus; 3H thymidine incorporation

Indexed keywords

EID: 0005922480     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1996.tb00213.x     Document Type: Article

References (23)

1. McDonald PJ, Craig WA, Kunin CM. Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. J Infect Dis 1981; 135: 217-23.
2. Craig WA, Gudmundsson S. The postantibiotic effect. In: Lorian V, ed. Antibiotics in laboratory medicine, 3rd edn. Baltimore: Williams & Wilkins, 1991: 403-31.
3. Gilbert DN. Once-daily aminoglycoside therapy. Antimicrob Agents Chemother 1991; 35: 399-405.
4. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann Intern Med 1993; 119: 584-93.
5. Prins JM, Büller HR, Kuijper EJ, Tange RA, Speelman P. Once versus thrice daily gentamicin in patients with serious infections. Lancet 1993; 341: 335-9.
6. Isaksson B, Nilsson L, Mailer R, Sörén L. Postantibiotic effect of aminoglycosides on Gram-negative bacteria evaluated by a new method. J Antimicrob Chemother 1988; 22: 23-33.
7. Odenholt I, Isaksson B, Nilsson L, Cars O. Postantibiotic and bactericidal effect of imipenem against Pseudomonas aeruginosa. Eur J Clinical Microbiol Infect Dis 1989; 8: 136-41.
8. Winstanley TG, Hastings JGM. Penicillin-aminoglycoside synergy and post-antibiotic effect for enterococci. J Antimicrob Chemother 1989; 23: 189-99.
9. Hanberger H, Nilsson LE, Kihlström E, Mailer R. Post-antibiotic effect of β-lactam antibiotics on Escherichia coli evaluated by bioluminescence assay of bacterial ATP. Antimicrob Agents Chemother 1990; 34: 102-6.
10. Shah PM, Huebner K-G, Stille W. In vitro-untersuchungen zur intermittierenden therapie mit penicillin G und ampicillin. Medizin Welt 1978; 29: 888-92.
11. Rescott DL, Nix DE, Holden P, Schentag JJ. Comparison of two methods for determining in vitro postantibiotic effects of three antibiotics on Escherichia coli. Antimicrob Agents Chemother 1988; 32: 450-3.
12. Li RC, Nix DE, Schentag JJ. New turbidimetric assay for quantitation of viable bacterial densities. Antimicrob Agents Chemother 1993; 37: 371-4.
13. Nadler HL, Curby WA, Forgacs P, Rosenberg F. Comparison of electronic and viability counting methods for determination of the postantibiotic effect of oxacillin on Staphylococcus aureus. Antimicrob Agents Chemother 1989; 33: 2155-6.
14. Gould IM, Jason AC, Milne K. Use of the Malthus microbial growth analyser to study the post antibiotic effect of antibiotics. J Antimicrob Chemother 1989; 24: 523-31.
15. Lorian V, Ernst J, Amaral L. The post-antibiotic effect defined by bacterial morphology. J Antimicrob Chemother 1989; 23: 485-91
16. Gottfredsson M, Erlendsdottir H, Kolka R, Gudmundsson A, Gudmundsson S. Ultrastructural alterations of bacteria during the postantibiotic effect. Chemotherapy 1993; 39: 153-62.
17. Guan L, Burnham JC. Postantibiotic effect of CI-960, enoxacin and ciprofloxacin on Escherichia coli: effect on morphology and hemolysin activity. J Antimicrob Chemother 1992; 29: 529-38.
18. 2 generation of bacteria with the BACTEC blood culture system. Antimicrob Agents Chemother 1991; 35: 2658-61.
19. Hanberger H, Svensson E, Nilsson LE, Nilsson M. Control-related effective regrowth time and postantibiotic effect of meropenem on Gram-negative bacteria studied by bioluminescence and viable counts. J Antimicrob Chemother 1995; 35: 585-92.
20. National Committee for Clinical Laboratory Standards. Methods for dilution susceptibility tests for bacteria that grow aerobically. Approved standard M7-A. Villanova, PA: National Committee for Clinical Laboratory Standards, 1985.
21. Engle EC, Manes SH, Drlica K. Differential effects of antibiotics inhibiting gyrase. J Bacteriol 1982; 149: 92-8.
22. Gottfredsson M, Erlendsdottir H, Gudmundsson A, Gudmundsson S. Different patterns of bacterial DNA synthesis during postantibiotic effect. Antimicrob Agents Chemother 1995; 39: 1314-19.
23. MacKenzie FM, Gould IM. The postantibiotic effect. J Antimicrob Chemother 1993; 32: 519-37.